bimatoprost 0.03%
bimatoprost 0.03% is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
10 of 10 finished
0.0%
0 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
Clinical Trials (10)
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Safety and Efficacy of a Drug Delivery System in Glaucoma
Lumigan Versus Cosopt
Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10